Assignee
LIPOCINE INC
US·75 granted patents·85 pending applications·9,316 citations·filing 1999–2025
Top patents by PatentIndex Score
160 records- 0199US9480690B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2015·Granted Nov 1, 2016·34 cites·24 claims
- 0299US6923988B2Solid carriers for improved delivery of active ingredients in pharmaceutical compositionsLIPOCINE INC·Filed 2003·Granted Aug 2, 2005·857 cites·88 claims
- 0399US6569463B2Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositionsLIPOCINE INC·Filed 2001·Granted May 27, 2003·941 cites·55 claims
- 0499US6451339B2Compositions and methods for improved delivery of hydrophobic agentsLIPOCINE INC·Filed 2001·Granted Sep 17, 2002·514 cites·120 claims
- 0599US6383471B1Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agentsLIPOCINE INC·Filed 1999·Granted May 7, 2002·1k cites·114 claims
- 0699US6309663B1Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agentsLIPOCINE INC·Filed 1999·Granted Oct 30, 2001·561 cites·170 claims
- 0799US6294192B1Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agentsLIPOCINE INC·Filed 1999·Granted Sep 25, 2001·929 cites·74 claims
- 0899US6267985B1Clear oil-containing pharmaceutical compositionsLIPOCINE INC·Filed 1999·Granted Jul 31, 2001·746 cites·184 claims
- 0999US6248363B1Solid carriers for improved delivery of active ingredients in pharmaceutical compositionsLIPOCINE INC·Filed 1999·Granted Jun 19, 2001·1.8k cites·57 claims
- 1098US11052096B2Steroidal compositionsLIPOCINE INC·Filed 2020·Granted Jul 6, 2021·6 cites·7 claims
- 1198US10973833B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2019·Granted Apr 13, 2021·8 cites·25 claims
- 1298US10881671B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2020·Granted Jan 5, 2021·5 cites·30 claims
- 1398US10716794B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2018·Granted Jul 21, 2020·9 cites·27 claims
- 1498US10226473B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2018·Granted Mar 12, 2019·23 cites·21 claims
- 1598US9949985B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2017·Granted Apr 24, 2018·23 cites·26 claims
- 1698US9943527B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2017·Granted Apr 17, 2018·18 cites·19 claims
- 1798US9757390B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2017·Granted Sep 12, 2017·27 cites·27 claims
- 1898US9498485B2Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one estersLIPOCINE INC·Filed 2015·Granted Nov 22, 2016·23 cites·1 claims
- 1998US9205057B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2015·Granted Dec 8, 2015·42 cites·26 claims
- 2098US7374779B2Pharmaceutical formulations and systems for improved absorption and multistage release of active agentsLIPOCINE INC·Filed 2002·Granted May 20, 2008·332 cites·86 claims
- 2198US6761903B2Clear oil-containing pharmaceutical compositions containing a therapeutic agentLIPOCINE INC·Filed 2001·Granted Jul 13, 2004·305 cites·122 claims
- 2298US6720001B2Emulsion compositions for polyfunctional active ingredientsLIPOCINE INC·Filed 1999·Granted Apr 13, 2004·469 cites·21 claims
- 2398US6468559B1Enteric coated formulation of bishosphonic acid compounds and associated therapeutic methodsLIPOCINE INC·Filed 2000·Granted Oct 22, 2002·169 cites·59 claims
- 2497US11931367B2Oral (17-ß)-3-oxoandrost-4-en-17-yl tridecanoate therapyLIPOCINE INC·Filed 2021·Granted Mar 19, 2024·7 cites·96 claims
- 2597US11370811B1(17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparation and useLIPOCINE INC·Filed 2020·Granted Jun 28, 2022·8 cites·22 claims
- 2697US10799513B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2018·Granted Oct 13, 2020·6 cites·7 claims
- 2797US9358241B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2014·Granted Jun 7, 2016·31 cites·20 claims
- 2897US8865695B2Steroidal compositionsLIPOCINE INC·Filed 2014·Granted Oct 21, 2014·37 cites·9 claims
- 2996US11672807B1Oral testosterone non-undecanoate therapyLIPOCINE INC·Filed 2020·Granted Jun 13, 2023·7 cites·53 claims
- 3096US10881670B2Oral testosterone tridecanoate therapyLIPOCINE INC·Filed 2019·Granted Jan 5, 2021·7 cites·42 claims
- 3196US9757389B2Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one estersLIPOCINE INC·Filed 2016·Granted Sep 12, 2017·8 cites·18 claims
- 3296US6458383B2Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparinLIPOCINE INC·Filed 2000·Granted Oct 1, 2002·139 cites·94 claims
- 3395US12156881B2Oral (17-β)-3-oxoandrost-4-en-17-yl tridecanoate therapyLIPOCINE INC·Filed 2024·Granted Dec 3, 2024·3 cites·31 claims
- 3495US11992496B1Oral testosterone therapyLIPOCINE INC·Filed 2023·Granted May 28, 2024·2 cites·30 claims
- 3595US10709716B217-hydroxyprogesterone ester-containing oral compositions and related methodsLIPOCINE INC·Filed 2019·Granted Jul 14, 2020·4 cites·12 claims
- 3695US10022384B217-hydroxyprogesterone ester-containing oral compositions and related methodsLIPOCINE INC·Filed 2016·Granted Jul 17, 2018·10 cites·13 claims
- 3795US6982281B1Pharmaceutical compositions and dosage forms for administration of hydrophobic drugsLIPOCINE INC·Filed 2000·Granted Jan 3, 2006·96 cites·33 claims
- 3894US12161651B1Oral testosterone therapyLIPOCINE INC·Filed 2024·Granted Dec 10, 2024·1 cites·30 claims
- 3994US11478485B1Compositions and methods for treating CNS disordersLIPOCINE INC·Filed 2022·Granted Oct 25, 2022·3 cites·30 claims
- 4094US11337987B1Compositions and methods for treating central nervous system disordersLIPOCINE INC·Filed 2021·Granted May 24, 2022·5 cites·26 claims
- 4194US9399069B217-Hydroxyprogesterone ester containing oral compositions and related methodsLIPOCINE INC·Filed 2015·Granted Jul 26, 2016·9 cites·26 claims
- 4293US11969434B1Oral allopregnanolone compositions and methods of useLIPOCINE INC·Filed 2022·Granted Apr 30, 2024·4 cites·33 claims
- 4393US11872235B1Bioavailable solid state (17-β)-Hydroxy-4-Androsten-3-one estersLIPOCINE INC·Filed 2022·Granted Jan 16, 2024·1 cites·20 claims
- 4492US11298365B2Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one estersLIPOCINE INC·Filed 2020·Granted Apr 12, 2022·2 cites·23 claims
- 4592US9358299B217-hydroxyprogesterone ester-containing oral compositions and related methodsLIPOCINE INC·Filed 2015·Granted Jun 7, 2016·7 cites·28 claims
- 4691US12208103B1Compositions and methods for treating CNS disordersLIPOCINE INC·Filed 2024·Granted Jan 28, 2025·2 cites·30 claims
- 4791US12186327B2Oral allopregnanolone compositions and methods of useLIPOCINE INC·Filed 2022·Granted Jan 7, 2025·2 cites·42 claims
- 4890US12409185B1Oral allopregnanolone compositions and methods of useLIPOCINE INC·Filed 2024·Granted Sep 9, 2025·1 cites·30 claims
- 4990US9364547B217-hydroxyprogesterone ester containing oral compositions and related methodsLIPOCINE INC·Filed 2014·Granted Jun 14, 2016·7 cites·20 claims
- 5090US9358298B217-hydroxyprogesterone ester containing oral compositions and related methodsLIPOCINE INC·Filed 2014·Granted Jun 7, 2016·7 cites·33 claims
Showing the top 50 of 160 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →